{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:19:04Z","timestamp":1753877944534,"version":"3.41.2"},"reference-count":12,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPGN rep."],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec><jats:label\/><jats:p>It is uncommon for a patient to have 2 different diagnoses contributing to neonatal cholestasis and poor growth. We present a 2\u2010month\u2010old female with extrahepatic biliary atresia status after Kasai procedure at 4 weeks old presenting with persistent neonatal cholestasis. The patient was admitted for intolerance of oral feeds, concern for cholangitis and Kasai failure, and nutritional optimization. She was found to have genetic testing positive for 2 rare cystic fibrosis transmembrane conductance regulator mutations and pancreatic insufficiency consistent with a possible diagnosis of cystic fibrosis\u2013related disease. We discuss the implications and management considerations in a patient with both biliary atresia and cystic fibrosis.<\/jats:p><\/jats:sec>","DOI":"10.1097\/pg9.0000000000000285","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T18:00:18Z","timestamp":1675188018000},"source":"Crossref","is-referenced-by-count":1,"title":["Biliary Atresia and Rare Concurrent Cystic Fibrosis Variant"],"prefix":"10.1002","volume":"4","author":[{"given":"Brandon","family":"Ang","sequence":"first","affiliation":[{"name":"Valley Children's Healthcare Madera CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navneet","family":"Singh","sequence":"additional","affiliation":[{"name":"UCSF Fresno Community Medical Regional Center Fresno CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Shaban","sequence":"additional","affiliation":[{"name":"Valley Children's Healthcare Madera CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Snider","sequence":"additional","affiliation":[{"name":"Valley Children's Healthcare Madera CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-012-0842-5"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.81.2.125"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.75.1.67"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.15475"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001803"},{"key":"e_1_2_5_7_1","unstructured":"The Clinical and Functional TRanslation of CFTR (CFTR2). Available at:http:\/\/cftr2.org. Accessed September 9 2022."},{"key":"e_1_2_5_8_1","first-page":"A3159","article-title":"A unique phenotype of a rare cystic fibrosis transmembrane regulator gene mutation: C.935_937deltct (p. Phe312del)","volume":"201","author":"Worthington E","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<108::AID-HUMU3>3.0.CO;2-G"},{"key":"e_1_2_5_10_1","first-page":"91","article-title":"Cystic fibrosis liver disease \u2013 from diagnosis to risk factors","volume":"55","author":"Ciuca IM","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2008.03.009"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/ped.2015.0552"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001334"}],"container-title":["JPGN Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/PG9.0000000000000285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T14:45:20Z","timestamp":1749739520000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/PG9.0000000000000285"}},"subtitle":["Case Report and Management Considerations"],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1097\/PG9.0000000000000285"],"URL":"https:\/\/doi.org\/10.1097\/pg9.0000000000000285","archive":["Portico"],"relation":{},"ISSN":["2691-171X","2691-171X"],"issn-type":[{"type":"print","value":"2691-171X"},{"type":"electronic","value":"2691-171X"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"article-number":"e285"}}